Puig L - Search Results

1

The safety of ustekinumab for the treatment of psoriatic arthritis.

López-Ferrer A, Laiz A, Puig L. López-Ferrer A, et al. Among authors: puig l. Expert Opin Drug Saf. 2017 Jun;16(6):733-742. doi: 10.1080/14740338.2017.1323864. Epub 2017 May 9. Expert Opin Drug Saf. 2017. PMID: 28441904 Review.

2

Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.

Vila AT, Puig L, Fernández-Figueras MT, Laiz AM, Vidal D, Alomar A. Vila AT, et al. Among authors: puig l. Br J Dermatol. 2005 Aug;153(2):417-23. doi: 10.1111/j.1365-2133.2005.06635.x. Br J Dermatol. 2005. PMID: 16086759

3

[Which patient is a candidate for treatment with efalizumab and why?].

Puig L. Puig L. Actas Dermosifiliogr. 2008 Jan;99 Suppl 1:51-61. doi: 10.1016/s0001-7310(08)76198-2. Actas Dermosifiliogr. 2008. PMID: 18341853 Free article. Review. Spanish.

4

[Psoriatic arthritis: what the dermatologist needs to know, part 1].

López-Ferrer A, Torrente-Segarra V, Puig L. López-Ferrer A, et al. Among authors: puig l. Actas Dermosifiliogr. 2010 Sep;101(7):578-84. Actas Dermosifiliogr. 2010. PMID: 20858384 Review. Spanish.

5

[Psoriatic arthritis: what the dermatologist needs to know, Part 2].

López-Ferrer A, Torrente-Segarra V, Puig L. López-Ferrer A, et al. Among authors: puig l. Actas Dermosifiliogr. 2010 Nov;101(9):742-8. Actas Dermosifiliogr. 2010. PMID: 21034704 Review. Spanish.

6

Ustekinumab in clinical practice: response depends on dose and previous treatment.

Ruiz Salas V, Puig L, Alomar A. Ruiz Salas V, et al. Among authors: puig l. J Eur Acad Dermatol Venereol. 2012 Apr;26(4):508-13. doi: 10.1111/j.1468-3083.2011.04325.x. Epub 2011 Nov 12. J Eur Acad Dermatol Venereol. 2012. PMID: 22077903 Review.

7

Treatment of severe psoriasis.

Puig L. Puig L. J Eur Acad Dermatol Venereol. 2012 Aug;26 Suppl 5:17-8. doi: 10.1111/j.1468-3083.2012.04606.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22758913

8

Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.

Puig L, Morales-Múnera CE, López-Ferrer A, Geli C. Puig L, et al. Dermatology. 2012;225(1):14-7. doi: 10.1159/000339864. Epub 2012 Aug 10. Dermatology. 2012. PMID: 22890275 Review.

9

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.

Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, Taberner R, Ferrán M, García-Bustinduy M, Romero-Maté A, Pedragosa R, García-Diez A, Daudén E. Navarro R, et al. Among authors: puig l. Br J Dermatol. 2013 Mar;168(3):609-16. doi: 10.1111/bjd.12045. Br J Dermatol. 2013. PMID: 22985451

10

Cardiovascular risk and psoriasis: the role of biologic therapy.

Puig L. Puig L. Actas Dermosifiliogr. 2012 Dec;103(10):853-62. doi: 10.1016/j.adengl.2012.02.004. Epub 2012 Nov 15. Actas Dermosifiliogr. 2012. PMID: 23157913 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

810 results

Search Page

Filters